• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Pain Management Therapeutics Market

Pain Management Therapeutics Market Analysis by Application (Indication- Cancer Pain, Neuropathic Pain, Chronic Back Pain Fibromyalgia, Fibromyalgia, Post-Operative Pain, Arthritic Pain and Migraine), (Therapeutics-Anesthetics, Anticonvulsants, Antidepressants, Opioids, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Other Non-narcotic Analgesic and Anti-migraine Agents)


Market Scenario:
Pain management is used to treat all types of pain that include neuropathic, musculoskeletal, and spinal pain disorder with early intervention and an accurate diagnosis. Pain management helps thousands of people each year effectively in an area of neurologists, orthopaedists, primary care by physicians and other healthcare pain management therapies. The pain management therapeutics is growing because of various factors that include growing geriatric population, increasing number of surgeries, changing lifestyle and the rising incidences of chronic disorders. As per National Health Interview Survey statistics surveyed in 2016, around 20% of world’s population had been suffering from chronic pain disorder. Migraine accounts for 30% of global burden disease that produces half of the world’s neurological disease related to disability.

Google tech giant has entered pain management market that has developed smart contact lenses so as to monitor glucose level in patients suffering from diabetics; however, this will save patients from the pain of pricking fingers for blood glucose test. Various devices block pain mechanism by blocking passage of the pain signals to reach the brain. Such as, neuro-stimulator device that uses mild frequencies of the current to block passage of pain signals.

The global pain management market is growing because of large patient population base, high efficacy proven by pain management devices, long-term pain management that is growing among the geriatric population, reimbursement scenario that has been established for spinal cord stimulation (SCS) in developed countries and development of pain management device. As per the statistics provided by the UN Population Division, the total proportion of people above 60 years has increased from 12% in 1950 to 22% in 2011 and is projected to reach 32% by 2050. On the other hand, factors restricting the growth of the pain management market globally are high purchase and procedural cost, less awareness of the availability of pain management device. Also less number of pain specialists, the gap existing between prevalence and chronic pain treatment and less number of pain management clinics in several developing countries restrain the growth of the market. 

However, side effects such as skin hypersensitivity, redness and hyper-pigmentation, and availability of substitutes such as pain relief medications are some of the major factors restraining the growth of global pain management devices market.

Business Intelligence:
Eli Lilly and Company acquired CoLucid Pharmaceuticals, Inc. in 2017 for $46.50 per share that is approximately $960 million.  This will enhance Eli Lilly’s existing portfolio in the pain management for migraine disorder. Moreover, the rise in outsourcing of the pharmaceuticals is expected to fuel pain management market growth.

The company will pursue FDA approval by 2018 that could be a substitute for opioids for cancer pain, chronic back pain and osteoarthritis (OA) for a new type of pain management drug. Eli Lilly and Pfizer announced that tanezumab used for the treatment of chronic low back pain (CLBP) and chronic pain for a patient with osteoarthritis (OA) has granted the fast track designation by U.S. Food and Drug Administration (FDA).  If approved tanezumab drug would be the first new class of the non-opioid chronic pain management. 
This report provides analysis of the pain management market that contains current industry trends, market size, market growth and demands, major players with their key strategies. It covers growth opportunities and market canvas in the coming years. The report has been made with an in-depth analysis along with inputs from the various industry experts. The research has been carried out with primary and secondary data sources and either supporting bottom-up or top-down approach.

Regional Analysis:
Based on region, the global pain management market is segmented into North America, Europe, Asia-Pacific, and LAMEA. The pain management market is growing due to increasing investment in research and development in various nations. Also, the growth of the market is mainly because of availability of the over-the-counter drugs in U.S and Canada of pain management treatment.

Major Players: 
Teva Pharmaceuticals Industries Ltd., GlaxoSmithKline plc, Merck & Co. Inc., Johnson & Johnson, Mallinckrodt, Novartis AG, Purdue Pharma LP, Abbott, Pfizer Inc., AstraZeneca plc, Endo Health Solutions, Eli Lilly & Company

Global Composite Testing Market Segmentation: 
By application

• Indication

  • Cancer Pain
  • Neuropathic Pain 
  • Chronic Back Pain Fibromyalgia
  • Fibromyalgia Post-Operative Pain 
  • Arthritic Pain 
  • Migraine

• Therapeutics

  • Anesthetics
  • Anticonvulsants
  • Antidepressants
  • Opioids

Tramadol
Oxycodones
Hydrocodones
Others (Codeine, Fentanyl ,Morphine, Meperidine, Methadone)

o Non-steroidal 
o Anti-inflammatory Drugs (NSAIDS)
o Other Non-narcotic Analgesic 
o Antimigraine Agents

Regions covered
• North America (U.S and Canada and rest of North America)
• Europe (Germany, France, Italy and Rest of Europe)
• Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
• LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)


									

	

Related Reports

Global Vapor Cartridge Industry Market Research Report

The Vapor Cartridge market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Vapor ...read more

Global Foot-And-Mouth Disease Vaccine Industry Market Research Report

The Foot-And-Mouth Disease Vaccine market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Bas ...read more

Global Galactosyl Transferases Industry Market Research Report

The Galactosyl Transferases market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on th ...read more

Global Hemorrhoids Drug Industry Market Research Report

The Hemorrhoids Drug market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Hemor ...read more

Global Meningococcal Polysaccharide Vaccine(Group A/C/Y/W135) Industry Market Research Report

The Meningococcal Polysaccharide Vaccine(Group A/C/Y/W135) market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.